Cannabis Clinical Trials

LAVAL, Quebec–(BUSINESS WIRE)–Altasciences is pleased to share that they are in the final stages of completing the world’s first safety and tolerability study on a cannabis extract being developed as a new chemical entity for approval by the FDA and Health Canada as a drug. Starting in January 2017, Altasciences combined their decades of experience designing […]

by

There are millions of people worldwide with chronic diseases and other medical conditions whose lives could be improved with better access to medical cannabis. Meanwhile, for the past decade and a half, Canada has built the most sophisticated medical cannabis framework in the world. These circumstances present an exceptional opportunity for trade leadership on the […]

by

Medical healing using cannabis harkens back thousands of years. Despite this long history of humans healing themselves with this plant, we are just beginning to come out of the dark ages about the medical benefits of cannabis. Cannabis was a part of the American pharmacopoeia until just before World War II. Starting in the late […]

by

In 1997, 28-year-old Oregon resident and stay-at-home mom Amy Mellen was pregnant with her second child when her physician prescribed Percocet for severe migraines that began when she was in college. “My migraines were debilitating,” Mellen shared. “It was impossible to care for my oldest daughter, while pregnant with my youngest daughter. I get vision […]

by

IRVINE, CA–(Marketwired – Aug 23, 2017) –  Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the launch of the Cannabis Science Global Consortium and to provide updates on the Company’s drug development initiatives and research collaborations. The Cannabis Science Global Consortium provides the […]

by

IRVINE, CA–(Marketwired – Aug 23, 2017) –  Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the launch of the Cannabis Science Global Consortium and to provide updates on the Company’s drug development initiatives and research collaborations. The Cannabis Science Global Consortium provides the […]

by

Whole-plant marijuana and its products are already used during palliative care outside of the traditional hospice and hospital settings. Santa Cruz, California, is home to the Wo/Men’s Alliance for Medical Marijuana, a cannabis collective that has been compared to a traditional hospice. Director Valerie Corral helped pass the country’s first medical cannabis law in part […]

by

Visit the Canadian Bioceutical Corp Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors. BCC to Enter Into Joint Venture With Israeli Pharmaceutical Company Panaxia Differentiation into high-growth market segment under new “Salus Bio-Pharma” brand JV will launch in Arizona Massachusetts and, post closing of the […]

by

NEW YORK, Aug. 22, 2017 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced results for the quarter ended June 30, 2017, and provided an overview of recent operational highlights. “The development of cannabinoid-based therapeutics continues to gather momentum in the U.S. and around the […]

by

Cannabis advocates are criticizing the Department of Veterans Affairs for wasting time and resources on recently published research that produced inconclusive results on the effects of medical marijuana in treating pain and post-traumatic stress disorder. “I find the funds spent on regurgitating these studies to be worthless,” said Sean Kiernan, a veteran and advocate for […]

by

Bod Australia (ASX:BDA) has completed the design for a Phase I clinical trial of its novel pharmaceutical grade cannabis extract and delivery system. The clinical trial represents a major step forward in Bod’s strategy of leveraging its naturally-sourced medicines and skincare business to build a high-growth medicinal cannabis business. The Phase I clinical trial will […]

by